Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
Select your state to see jurisdictional framework, reporting obligations, and authority links. Substance information above is the same in every state.
“Ropinirole hydrochloride is a non-ergot dopamine agonist created based on the structure of dopamine, and exhibits antiparkinsonian effects by stimulating dopamine D 2 like receptors.”
“Consistent with its high lipophilicity, ropinirole exhibits a large volume of distribution (approximately 7 L/kg) and is cleared from the systemic circulation with an average elimination half-life of about 10 hours after transdermal administration.”
Working under the parallel aged-care framework? Aged-care equivalent →
Curated subset. The full adverse-effect list is in the TGA Product Information; click any citation above to open it.
“It has been established from in vitro experiments that ropinirole is principally metabolised by the cytochrome P450 enzyme CYP1A2.”